GSK - 37 Year Stock Price History | GSK

Historical daily share price chart and data for GSK since 1986 adjusted for splits. The latest closing stock price for GSK as of February 06, 2023 is 35.34.
  • The all-time high GSK stock closing price was 56.93 on April 13, 2022.
  • The GSK 52-week high stock price is 58.71, which is 66.1% above the current share price.
  • The GSK 52-week low stock price is 28.46, which is 19.5% below the current share price.
  • The average GSK stock price for the last 52 weeks is 43.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
GSK Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 35.1238 35.2900 35.6100 34.4800 35.3400 0.57%
2022 44.0945 52.3023 56.9329 28.3838 35.1400 -33.47%
2021 45.7581 42.7277 53.2245 38.7500 52.8173 26.77%
2020 44.2596 50.5204 51.5648 34.7487 41.6635 -17.65%
2019 43.6608 38.8260 50.9511 38.7747 50.5957 29.19%
2018 39.4378 35.8613 42.9156 34.4630 39.1642 13.71%
2017 38.0186 35.7970 41.9438 33.6570 34.4436 -2.96%
2016 37.2327 34.9494 41.0075 33.6102 35.4928 1.81%
2015 36.4313 34.6843 40.5434 32.0232 34.8630 -0.35%
2014 40.2285 41.0294 44.4486 33.8084 34.9872 -15.68%
2013 37.9276 32.6805 41.4957 32.5324 41.4957 28.90%
2012 32.6354 32.4339 34.6602 30.6468 32.1917 0.67%
2011 28.5463 26.1030 32.0555 24.1611 31.9784 22.60%
2010 24.7546 27.0899 27.4845 20.9634 26.0831 -2.08%
2009 22.4708 22.1476 27.0520 16.5642 26.6360 19.30%
2008 25.2518 28.5983 30.9868 19.1822 22.3273 -22.27%
2007 29.9507 29.5418 32.8912 27.2873 28.7238 -0.83%
2006 29.1100 27.0871 31.5423 26.6565 28.9654 7.95%
2005 25.6230 24.4018 28.4531 22.9227 26.8319 9.87%
2004 21.5383 23.2422 24.4791 19.7839 24.4224 5.55%
2003 19.8243 18.4672 23.5251 15.9049 23.1380 28.80%
2002 20.1470 23.2103 23.6853 15.5078 17.9637 -22.56%
2001 24.7833 25.6138 26.6860 22.3685 23.1964 -9.63%
2000 25.0692 24.2920 28.2307 20.1122 25.6688 5.06%
1999 25.4532 30.0402 31.9966 21.0594 24.4319 -16.98%
1998 24.6193 19.9999 29.4304 19.9999 29.4304 47.92%
1997 16.4444 12.8248 19.9459 12.3138 19.8960 53.28%
1996 11.3195 11.0814 13.9000 9.3879 12.9802 17.14%
1995 9.1557 7.8628 11.0814 7.1583 11.0814 44.39%
1994 6.8319 7.5914 8.0059 5.8326 7.6744 2.30%
1993 6.6414 8.2656 8.2656 5.2150 7.5016 -8.79%
1992 9.3182 10.7963 11.7719 7.7046 8.2241 -23.54%
1991 7.3982 5.4297 10.7556 5.1390 10.7556 98.88%
1990 4.5684 4.1076 5.7187 3.6482 5.4082 30.40%
1989 3.5886 2.9895 4.2065 2.8730 4.1475 38.74%
1988 2.7536 2.8522 3.1246 2.4378 2.9895 8.37%
1987 3.5578 2.2784 4.5152 2.2784 2.7585 21.07%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $71.300B $36.279B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00